Raw data 1–5. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Raw data 10–14. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Coordination angle during running. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Gait retraining with biofeedback. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

Coordination angle during walking. by Fateme Khorramroo (18086501)

“…Transverse ankle-hip coordination showed an in-phase pattern in wide conditions during push-off (p=0.044), during LR (p=0.022). Wide walking, significantly increased coordination variability of the sagittal ankle-knee during LR and decreased transverse ankle-hip during push-off. …”

The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment... by Flavia Cerasti (21655934)

A) RT-qPCR analysis of <i>Yap</i>, <i>Taz</i>, and <i>Tead2</i> shows a significant decrease in transcript levels over postnatal stages from P0 to P28. by Heather L. Dingwall (14573796)

Difference in by Akihiro Kakimoto (343218)

Subjects:

Experimental protocol. by Akihiro Kakimoto (343218)

Subjects:

Relationship between the change in by Akihiro Kakimoto (343218)

Subjects:

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Study selection criteria. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

PICOS criteria for the SLR. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects: